New review from the May 1 issue—
NCI Cancer Research Data Commons: Cloud-Based Analytic Resources, by David Pot et al.
aacrjournals.org/cancerres/arti…
NCI Cancer Data Science

New review from the May 1 issue—
NCI Cancer Research Data Commons: Core Standards and Services, by Arthur Brady et al.
aacrjournals.org/cancerres/arti…
NCI Cancer Data Science

REGISTER NOW! for our 2-part webinar series on QUALITY DEFECTS AND METHODS OF REPRODUCIBILITY IN BIOMEDICAL RESEARCH May 14 & 21. For more information and to register, visit fnlm.org/product/qualit…

New review from the May 1 issue—
NCI Cancer Research Data Commons: Resources to Share Key Cancer Data, by Zhining Wang et al.
aacrjournals.org/cancerres/arti…
NCI Cancer Data Science

Stay up to date with the latest Cancer Research #OnlineFirst articles.
bit.ly/4a9YO4k

#OnlineFirst : Read the In the Spotlight commentary, Warburg Effect Reshapes Tumor Immunogeneicity, by Maria Mittelbrunn and Jose Enriquez, discussing a recent Nature Cancer paper from Ed Reznik, Payam A. Gammage et al.
bit.ly/3y23trt

New review from the May 1 issue—
NCI Cancer Research Data Commons: Lessons Learned and Future State, by Erika Kim et al.
bit.ly/3yah3cs
NCI Cancer Data Science

New research on alveolar soft part sarcoma (ASPS) by
Matt Hemming is featured on the Cancer Center website. The team delved into the mechanistic underpinnings of ASPS revealing a targetable vulnerability. Check it out!
UMass Chan Medical School
Department of Medicine
Cancer Research
bit.ly/4dymqCD

In a study supported by #PSON , Rosalind Segal et al. showed that inhibitors of EYA1 (a phosphatase and transcription factor) suppress tumor growth in preclinical models of SHH medulloblastoma Cancer Research aacrjournals.org/cancerres/arti…. #BTSM #BTAM

Join our community of authors. Learn about our Convergence Science section and submit your article:
bit.ly/4a4v60s

New in Convergence Science from the May 1 issue—
Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with EMT & Inflammation in Cancer Cells in PDAC, by Samantha Guinn, Richard Burkhart, Dr. Elana J Fertig, Jackie Zimmerman et al.
bit.ly/3JK9tHX
Convergence Institute

Biological basis of cancer disparities, the cancer macroenvironment, systems level analyses of cancer biology and progression, and mechanisms of resistance—discover why these areas of convergence research are of particular interest to Cancer Research:
bit.ly/3JGovyu

.Matt Hemming uncovered ASPSCR1::TFE3's role in alveolar soft part sarcoma. Their Cancer Research
paper highlights promising strategies targeting angiogenesis and cell cycle regulation. Check it out! bit.ly/3QnDFfN
@UMasschan Department of Medicine

Happy to share our latest paper from Cancer Research. Ito and colleagues reveal the genetic landscape of ENKTCL evaluating a total of 178 patients with extranodal NK/T-cell lymphoma (ENKTCL) including 114 and 64 patients from France and Japan, respectively. doi.org/10.1158/0008-5…

Now out in Cancer Research: We mine the epigenetic underpinnings of #AlveolarSoftPartSarcoma utilizing patient samples, preclinical models, and functional tags (dTAG, BioID) to define the oncogenic transcriptional program driven by ASPSCR1::TFE3 and actionable therapeutic liabilities:

Thrilled to share the latest commentary by the Scherz Shouval Lab exploring age-related changes in pancreatic fibroblasts and their impact on cancer progression! Had a blast writing with Debra Barki on the fascinating work by Zabransky et al. Ashi_W Cancer Research
doi.org/10.1158/0008-5…

Thank you ⁦AACR⁩ for the highlight of our recent publication w/ Stanley Lee in ⁦Cancer Research⁩. ⁦UMN Pharmacology and MPaT⁩ ⁦Masonic Cancer Center, University of Minnesota⁩ ⁦UMN Medical School⁩ aacr.org/professionals/…

Been out a while, but better late tweet than never; NPEPPS as target in #cisplatin resistant #bladdercancer in Cancer Research ! By Robert Jones , Tahlita Zuiverloon MD PhD , Dan Theodorescu , Jim Costello. congrats!
NPEPPS Is a Druggable Driver of Platinum Resistance aacrjournals.org/cancerres/arti…